Of note, the extent of T cell accrual within CRC tumors, regardless of MSI status, is prognostic for survival (17), suggesting that T cells are functional in CRC and stimulating T cell recruitment into the TME might sensitize MSS patients to PD-(L)1 blockade. This evidence concerns the gene CD274 and colorectal carcinoma.